WEBINAR: Clinical Outcome Assessments (COAs) – Developing and Defending Effective Endpoint Strategies
Event Date - June 14 2012 11:00 am
Presented by:
Dr. Chad Gwaltney
Dr. Chad Gwaltney, Senior Director, Consulting Services, invivodata, inc.
In this webinar, Dr. Gwaltney will present an overview of the FDA’s current position on Clinical Outcome Assessments (COAs) and its implications for product labeling. The discussion will focus on the type of work needed to develop an effective endpoint strategy and the materials expected by regulators to defend that strategy when COAs are used in clinical research.